Bronchodilator resuscitation in the emergency department Part 2 of 2: Dosing strategies

Respiratory Care

Volumn 45, Issue 5, 2000, Pages 497-512

  Fink, James ^a,b,c   Dhand, Rajiv ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b AeroGen   (United States)

^c AeroGen Inc   (United States)

Author keywords

Acute airway obstruction; Aerosol therapy; Anticholinergics; Beta agonists; Bronchodilator resuscitation; Continuous nebulizer therapy; Dosing strategies; Emergency department; Intermittent nebulizer therapy

Indexed keywords

ADRENALIN; BITOLTEROL; BRONCHODILATING AGENT; FENOTEROL; IPRATROPIUM BROMIDE; PIRBUTEROL; PREDNISONE; SALBUTAMOL; TERBUTALINE;

AIRWAY OBSTRUCTION; BRONCHODILATATION; CLINICAL EXAMINATION; DOSE CALCULATION; DRUG CHOICE; EMERGENCY WARD; FORCED EXPIRATORY VOLUME; HUMAN; NEBULIZATION; PEAK EXPIRATORY FLOW; RESUSCITATION; REVIEW; TREATMENT INDICATION;

ADMINISTRATION, INHALATION; ADRENERGIC BETA-AGONISTS; AEROSOLS; AIRWAY OBSTRUCTION; ALBUTEROL; ASTHMA; BRONCHODILATOR AGENTS; CHOLINERGIC ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; EMERGENCY SERVICE, HOSPITAL; FENOTEROL; HUMANS; NEBULIZERS AND VAPORIZERS; RESUSCITATION; TREATMENT OUTCOME;

EID: 0034077466     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Fink J, Dhand R Bronchodilator resuscitation in the emergency department. Part 1 of 2: Device selection. Respir Care 1999;44(11): 1353-1374.
2. Physicians' desk reference. 53rd ed. Montvale. NJ: Medical Economics Co, 1999.
3. National Asthma Education and Prevention Program Expert Panel Report II. Guidelines for the diagnosis and management of asthma, National Institutes of Health, 1997.
4. Newhouse MT, Chapman KR, McCallum AL, Abboud RT, Bowie DM, et al. Cardiovascular safety of high doses of inhaled fenoterol and albuterol in acute severe asthma. Chest 1996;110(3):595-603.
5. Rodrigo C, Rodrigo G. High-dose MDI salbutamol treatment of asthma in the ED. Am J Emerg Med 1995;13(1):21-26.
6. Lin YZ, Hsieh KH. Metered dose inhaler and nebulizer in acute asthma, Arch Dis Child 1995;72(3):214-218.
7. Rodrigo G, Rodrigo C. Metered dose inhaler salbutamol treatment of asthma in the ED: comparison of two doses with plasma levels. Am J Emerg Med 1996;14(2) 144-150.
8. Schuh S, Reider MJ, Canny G, Pender E, Forbes T, Tan YK, et al. Nebulized albuterol in acute childhood asthma: comparison of two doses. Pediatrics 1990;86(4):509-513.
9. Colacone A, Afilalo M, Wolkove N, Kreisman H A comparison of albuterol administered by metered dose inhaler (and holding chamber) or wet nebulizer in acute asthma. Chest 1993;104(3):835-841.
10. Kerem E, Levison H, Schuh S, O'Brodovich H, Reisman J, Bentur L. Canny GJ. Efficacy of albuterol administered by nebulizer versus spacer device in children with acute asthma. J Pediatr 1993;123(2): 313-317
11. Rodrigo G, Rodrigo C. Salbutamol treatment of acute severe asthma in the ED: MDI versus hand-held nebulizer. Am J Emerg Med 1998; 16(7) 637-642.
12. Rodrigo G, Rodrigo C. Comparison of salbutamol delivered by nebulizer or metered-dose inhaler with a pear-shaped spacer in acute asthma. Current Therapeutic Research, Clinical & Experimental 1993; 54(6):800-808.
13. Blake KV, Hoppe M, Harman E, Hendeles L. Relative amount of albuterol delivered to lung receptors from a metered-dose inhaler and nebulizer solution: bioassay by histamine bronchoprovocation. Chest 1992;101(2).309-315.
14. Strauss L, Hejal R, Galan G, Dixon L, McFadden ER Jr. Observauons on the effects of aerosolized albuterol in acute asthma. Am J Respir Crit Care Med 1997,155(2):454-458.
15. Rodrigo C. Rodrigo G. Therapeutic response patterns to high and cumulative doses of salbutamol in acute severe asthma. Chest 1998; 113(3):593-598.
16. Emerman CL, Cydulka RK, McFadden ER. Comparison of 2.5 vs 7.5 mg of inhaled albuterol in the treatment of acute asthma. Chest 1999. 115(1):92-96.
17. aCO2 in children with severe asthma treated with continuously nebulized terbutaline. J Allergy Clin Immunol 1988;81(6): 1101-1109.
18. Papo MC, Frank J, Thompson AE A prospective, randomized study of continuous versus intermittent nebulized albuterol for severe status asthmaticus in children. Crit Care Med 1993;93(10):1479-1486.
19. Katz RW, Kelly HW, Crowley MR, Grad R, McWilliams BC, Murphy SJ. Safety of continuous nebulized albuterol for bronchospasm in infants and children. Pediatrics 1993;92(5):666-669.
20. Lin RY, Sauter D, Newman T, Sirleaf J, Walters J, Tavakol M. Continuous versus intermittent albuterol nebulization in the treatment of acute asthma. Ann Emerg Med 1993;22(12):1847-1853.
21. Rudmtsky GS, Eberlein RS, Schoffstall JM, Mazur JE, Spivey WH. Comparison of intermittent and continuously nebulized albuterol for treatment of asthma in an urban emergency department. Ann Emerg Med 1993;93(12):1842-1846.
22. Lin RY, Smith AJ, Hergenroeder P. High serum albuterol levels and tachycardia in adults asthmatics treated with high-dose continuously aerosolized albuterol Chest 1993;103(1):221-225.
23. Moler FW, Johnson CE, Van Laanen C, Palmisano JM, Nasr SZ, Akingbola O Continuous versus intermittent nebulized terbutaline: plasma levels and effects. Am J Respir Crit Care Med 1995;151(3 pt 1):602-606.
24. Reisner C, Kotch A, Dworkin G. Continuous versus frequent intermittent nebulization of albuterol in acute asthma: a randomized, prospective study. Ann Allergy Asthma Immunol 1995;75(1): 41-47
25. Levitt MA, Gambrioli EF, Fink JB. Comparative trial of continuous nebulization versus metered-dose inhaler in the treatment of acute bronchospasm. Ann Emerg Med 1995;26(3):273-277.
26. Khine H, Fuchs SM, Saville AL. Continuous vs intermittent nebulized albuterol for emergency management of asthma. Acad Emerg Med 1996;96(3):1019-1024.
27. Shrestha M, Bidadi K, Gourlay S, Hayes J Continuous vs intermittent albuterol. at high and low doses, in the treatment of severe acute asthma in adults. Chest 1996;110(1):42-47.
28. Baker EK, Willsie SK, Marinac JS, Salzman GA. Continuously nebulized albuterol in severe exacerbations of asthma in adults: a case-controlled study. J Asthma 1997;34(6).521-530.
29. Raabe OG, Wong TM, Wong GB, Roxburgh JW, Piper SD, Lee JI. Continuous nebulization therapy for asthma with aerosols of beta2 agonists. Ann Allergy Asthma Immunol 1998,80(6):499-508.
30. Fink JB, Calebaugh JD, Dhand R, Secondary flow of air and heliox through a closed dilution nebulizer improves bronchodilator delivery (abstract). Respir Care 1998;43(10).870
31. Berlinski A, Waldrep JC. Four hours of continuous albuterol nebulization. Chest 1998;114(3):847-853.
32. McPeck M, Tandon R, Hughes K, Smaldone GC. Aerosol delivery during continuous nebulization. Chest 1997;111(5):1200-1205.
33. Campbell S For COPD a combination of ipratropium bromide and albuterol sulfate is more effective than albuterol base. Arch Intern Med 1999,159(2):156-160
34. Gross N, Tashkin D, Miller R, Oren J, Coleman W. Lindberg S Inhalation by nebulization of albuterol-ipratropium combination (Dey combination) is superior to either agent alone in the treatment of chronic obstructive pulmonary disease. Dey Combination Solution Study Group. Respiration 1998;65(5):354-362.
35. Everard ML, Kurian M. Anti-cholinergic therapy for treatment of wheeze in children under the age of two years. The Cochrane Library (Oxford) 1999;issue 1(9p)
36. Karpel JP, Schacter EN, Fanta C, Levy D, Spiro P, Aldrich T, et al. A comparison of ipratropium and albuterol vs albuterol alone for the treatment of acute asthma Chest 1996,110(3):611-616.
37. McFadden ER, ElSanadi N, Strauss L, Galan G, Dixon L, McFadden CB, et al The influence of parasympatholytics on the resolution of acute attacks of asthma. Am J Med 1997;102(1):7-13
38. Qureshi F, Zantsky A, Lakkis H Efficacy of nebulized ipratropium in severely asthmatic children. Ann Emerg Med 1997;29(2):205-211
39. Qureshi F, Pestian J, Davis P, Zaritsk A. Effect of nebulized ipratropium on the hospitalization rates of children with asthma. N Engl J Med 1998;339(15):1030-1035.
40. Zorc JJ, Pusic MV, Ogborn CJ, Lebet R, Duggan AK. Ipratropium bromide added to asthma treatment in the pediatric emergency department. Pediatrics 1999;103(4):748-752.
41. Lanes SF, Garret JE, Wentworth CE 3rd, Fitzgerald JM, Karpel JP. The effect of adding ipratropium bromide to salbutamol in the treatment of acute asthma: a pooled analysis of three trials, Chest 1998; 114(2):365-372.
42. Lin RY, Pesola GR, Bakalchuk L, Morgan JP, Heyl GT, FreyberaCW, et al. Superiority of ipratropium plus albuterol over albuterol alone in the emergency department management of adult asthma: a randomized clinical trial. Ann Emerg Med 1998;31(2):208-213.
43. Ducharme FM, Davis GM, Randomized controlled trial of ipratropium bromide and frequent low doses of salbutamol in the management of mild and moderate acute pediatric asthma. J Pediatr 1998; 133 (4).479-485.
44. Weber EJ, Levitt MA, Covington JK, Gambrioli E. Effect of conunuously nebulized ipratropium bromide plus albuterol on emergency department length of stay and hospital admission rates in patients with acute bronchospasm. A randomized, controlled trial. Chest 1999;115(4):937-944.
45. Stoodley RG, Aaron SD, and Dales RE. The role of ipratropium bromide in the emergency management of acute asthma exacerbation: a metaanalysis of randomized clinical trials. Ann Emerg Med 1999;34(1):8-18.